의약품 전자상거래 시장 : 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, pharmaceutical e-commerce market size in 2026 is estimated at USD 262.25 billion, growing from 2025 value of USD 234.95 billion with 2031 projections showing USD 454.43 billion, growing at 11.62% CAGR over 2026-2031.

This report is Segmented by Type (Prescription and Over-The-Counter), Product Type (Vaccines, and More), Therapeutic Area (Diabetes, and More), Market Type (B2B, B2B2B, B2B2C, and B2C), Platform (Manufacturer-Owned Digital Commerce, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Pharmaceutical E-commerce Market Trends and Insights

Rapid Expansion of Digital Health Infrastructure

Digital health infrastructure now links electronic medical records, payment gateways, and cloud-based inventory systems in real time, enabling frictionless prescription validation and fulfillment. Amazon's plan to open 20 additional on-site pharmacies in 2025 will extend same-day delivery to 45% of U.S. households, demonstrating how infrastructure spending quickly scales market access. Global logistics providers such as UPS Healthcare have added GDP/GMP-compliant cold-chain capacity across 220 countries, simplifying cross-border shipments of temperature-sensitive biologics. Improved connectivity cuts dispensing errors, reduces lead times, and expands specialty drug coverage to rural zones that previously relied on infrequent deliveries. The net result is an ecosystem where early movers lock in supply-chain efficiencies that are difficult for late entrants to replicate.

Rising Adoption of Telemedicine and E-Prescription Services

Telemedicine platforms eliminate the gap between consultation and dispensing by routing e-prescriptions directly to partnered online pharmacies. Updated DEA regulations now permit controlled-substance prescribing via telehealth under a Special Registration framework, removing a major barrier to digital fulfilment. Eli Lilly's LillyDirect integrates virtual visits with direct-to-home shipment of diabetes, obesity, and migraine drugs through Amazon Pharmacy, offering a unified experience that boosts adherence and reduces travel time. In rural areas where clinician shortages persist, telemedicine-e-pharmacy linkages reduce clinical inertia and ensure timely therapy initiation. This synergy also lowers payer costs by minimizing emergency visits tied to medication lapses.

Stringent and Fragmented Regulatory Frameworks

Compliance complexity rises when state, federal, and supranational rules evolve at different speeds. The FDA ended its stabilization period for enhanced drug-distribution security in November 2024, compelling all large pharmacies to meet end-to-end traceability standards, while small outlets remain exempt until late 2026. Simultaneously, the European Union's first sweeping pharmaceutical-legislation overhaul in two decades introduces new digital-dispensing requirements, challenging platforms that operate across multiple member states. Such divergence inflates legal costs and slows cross-border scaling, favoring well-capitalized players that can absorb documentation, auditing, and serialization expenses.

Other drivers and restraints analyzed in the detailed report include:

1. Growing Consumer Preference for Convenient Home Delivery
2. Increasing Burden of Chronic Diseases and Aging Population
3. Prevalence of Counterfeit and Substandard Medicines Online

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Prescription drugs held 67.62% of Pharmaceutical E-commerce Market share in 2025, reflecting entrenched clinical oversight and reimbursement pathways tied to physician authorization. Over-the-counter items, however, expand at a 14.12% CAGR through 2031, signaling consumer willingness to self-treat common ailments without clinician visits. The FDA's Additional Conditions for Nonprescription Use (ACNU) Final Rule, effective January 2025, creates a pathway for digital self-selection tools that could reclassify select chronic-disease therapies as nonprescription, accelerating OTC substitution.

The segment outlook suggests that platform operators able to layer decision-support algorithms on product pages will capture growth as consumers consult apps before checkout. Subscription refills tied to OTC vitamins, allergy treatments, and pain relievers further diversify revenue and offset seasonal revenue dips. Meanwhile, prescription dominance persists where insurance mandates prior authorization, yet telehealth reduces friction by converting video consultations into instant electronic prescribing. The resulting convergence blurs categorical lines, reinforcing the Pharmaceutical E-commerce Market as a single continuum rather than two siloed segments.

General medicines contributed 43.71% of revenue in 2025, encompassing high-volume categories such as antihypertensives and antibiotics. Vaccines, though lower in base revenue, are set to climb at a 15.32% CAGR, driven by mRNA innovation and expanded adult-immunization initiatives. Lab teams have demonstrated microneedle printers capable of producing thermostable COVID-19 mRNA doses, potentially reducing cold-chain dependence and unlocking wider postal delivery.

As national immunization programs widen catch-up schedules for shingles, HPV, and pneumococcal shots, online pharmacies that integrate appointment booking with doorstep delivery or in-home administration gain an edge. Specialty cold-chain couriers continue to refine box-level temperature trackers that maintain 2-8 °C for 35 hours, a milestone that broadens viable shipping windows. General medicines remain the revenue anchor, but platform branding increasingly highlights immunization convenience, enhancing user acquisition during seasonal flu campaigns.

Complete Report Scope:

• By Type
  • Prescription
  • Over-The-Counter (OTC)
• By Product Type
  • Vaccines
  • Specialty Care
  • General Medicines
  • Consumer Healthcare
• By Therapeutic Area
  • Diabetes
  • Immune-System Diseases
  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Other Therapeutic Areas
• By Market Type
  • B2B
  • B2B2B
  • B2B2C
  • B2C
• By Platform
  • Manufacturer-Owned Digital Commerce
  • Distributor/Wholesaler-Owned Digital Commerce
  • Manufacturer-Owned Marketplace
  • Third-Party Marketplace
  • Retail
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 39.71% of global revenue in 2025, benefiting from mature broadband penetration, widespread e-prescription mandates, and consumer familiarity with doorstep delivery. Amazon's forthcoming 20 brick-and-mortar pharmacies and Walmart's same-day Rx coverage across 49 states highlight how existing logistics grids translate into pharma dominance. Policy harmonization-illustrated by the DEA's Special Registration for telehealth prescribing-further reduces friction for cross-state dispensing. Yet consolidation pressures remain: Walgreens' pending USD 23.7 billion leveraged buy-out aims to accelerate digital rebuilding outside public market scrutiny.

Asia-Pacific is the fastest-growing territory, forecast at a 13.12% CAGR through 2031. China lifted pilot restrictions on online prescription drug sales, India expanded its Unified Payments Interface to facilitate secure health-service payments, and Japan is legalizing most OTC e-sales by 2025, establishing fertile regulatory soil. Rising middle-class income and mobile-first habits speed adoption. Health-ministry drives in Saudi Arabia and the UAE back large-scale e-health implementations, suggesting spill-over demand for e-pharmacy in neighboring Gulf Cooperation Council states.

Europe maintains steady, mid-single-digit momentum as the common logo for registered online pharmacies improves consumer confidence. National rules still diverge on cold-chain shipping and advertising, however, moderating upside. South America and parts of Africa present earlier-stage opportunities; Brazil's e-commerce-friendly payment innovations and Nigeria's last-mile logistics start-ups offer templates but infrastructure and regulatory gaps persist. Collectively, these trends ensure the Pharmaceutical E-commerce Market evolves at different speeds, requiring region-specific compliance and service models.

1. Amazon Pharmacy
2. DocMorris (Zur Rose Group)
3. CVS Health
4. Walgreens Boots Alliance
5. Express Scripts
6. Rite Aid
7. Giant Eagle, Inc
8. OptumRx
9. NetMeds
10. Tata 1mg
11. PharmEasy
12. Apollo Pharmacy
13. Alibaba Health
14. JD Health
15. Chemist Warehouse
16. E-MedStore
17. Shop-Apotheke
18. Apoteket
19. Clicks Group
20. Flipkart Health+

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rapid Expansion of Digital Health Infrastructure
  • 4.2.2 Rising Adoption of Telemedicine and E-Prescription Services
  • 4.2.3 Growing Consumer Preference for Convenient Home Delivery
  • 4.2.4 Increasing Burden of Chronic Diseases and Aging Population
  • 4.2.5 Government Initiatives Promoting Online Pharmaceutical Sales
  • 4.2.6 Venture Capital Investment Fueling E-Pharmacy Platforms
• 4.3 Market Restraints
  • 4.3.1 Stringent and Fragmented Regulatory Frameworks
  • 4.3.2 Prevalence of Counterfeit and Substandard Medicines Online
  • 4.3.3 Limited Cold-Chain Logistics Capability for Temperature-Sensitive Drugs
  • 4.3.4 Digital Literacy Gaps Among Elderly and Rural Populations
• 4.4 Regulatory Landscape
• 4.5 Porter's Five Forces Analysis
  • 4.5.1 Threat Of New Entrants
  • 4.5.2 Bargaining Power Of Buyers
  • 4.5.3 Bargaining Power Of Suppliers
  • 4.5.4 Threat Of Substitutes
  • 4.5.5 Intensity Of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Type
  • 5.1.1 Prescription
  • 5.1.2 Over-The-Counter (OTC)
• 5.2 By Product Type
  • 5.2.1 Vaccines
  • 5.2.2 Specialty Care
  • 5.2.3 General Medicines
  • 5.2.4 Consumer Healthcare
• 5.3 By Therapeutic Area
  • 5.3.1 Diabetes
  • 5.3.2 Immune-System Diseases
  • 5.3.3 Cancer
  • 5.3.4 Neurodegenerative Diseases
  • 5.3.5 Cardiovascular Diseases
  • 5.3.6 Other Therapeutic Areas
• 5.4 By Market Type
  • 5.4.1 B2B
  • 5.4.2 B2B2B
  • 5.4.3 B2B2C
  • 5.4.4 B2C
• 5.5 By Platform
  • 5.5.1 Manufacturer-Owned Digital Commerce
  • 5.5.2 Distributor/Wholesaler-Owned Digital Commerce
  • 5.5.3 Manufacturer-Owned Marketplace
  • 5.5.4 Third-Party Marketplace
  • 5.5.5 Retail
• 5.6 Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
  • 6.3.1 Amazon Pharmacy
  • 6.3.2 DocMorris (Zur Rose Group)
  • 6.3.3 CVS Health
  • 6.3.4 Walgreens Boots Alliance
  • 6.3.5 Express Scripts
  • 6.3.6 Rite Aid
  • 6.3.7 Giant Eagle, Inc
  • 6.3.8 OptumRx
  • 6.3.9 NetMeds
  • 6.3.10 Tata 1mg
  • 6.3.11 PharmEasy
  • 6.3.12 Apollo Pharmacy
  • 6.3.13 Alibaba Health
  • 6.3.14 JD Health
  • 6.3.15 Chemist Warehouse
  • 6.3.16 E-MedStore
  • 6.3.17 Shop-Apotheke
  • 6.3.18 Apoteket
  • 6.3.19 Clicks Group
  • 6.3.20 Flipkart Health+

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment